These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 27506851

  • 1. Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.
    Matera MG, Page C, Rogliani P, Calzetta L, Cazzola M.
    Drugs; 2016 Sep; 76(13):1257-1270. PubMed ID: 27506851
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water.
    Matera MG, Calzetta L, Cazzola M.
    Pulm Pharmacol Ther; 2010 Apr; 23(2):121-8. PubMed ID: 19853667
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. What's in the pipeline? Prospects for monoclonal antibodies (mAbs) as therapies for lung diseases.
    Li L, Das AM, Torphy TJ, Griswold DE.
    Pulm Pharmacol Ther; 2002 Apr; 15(5):409-16. PubMed ID: 12406662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Perspectives for cytokine antagonist therapy in COPD.
    de Boer WI.
    Drug Discov Today; 2005 Jan 15; 10(2):93-106. PubMed ID: 15718158
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Dentener MA, Wouters EF.
    N Engl J Med; 2006 Nov 09; 355(19):2047-8; author reply 2048. PubMed ID: 17099951
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Emerging anti-inflammatory strategies for COPD.
    Cazzola M, Page CP, Calzetta L, Matera MG.
    Eur Respir J; 2012 Sep 09; 40(3):724-41. PubMed ID: 22496331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytokine and chemokine blockade as immunointervention strategy for the treatment of diffuse lung diseases.
    Agostini C.
    Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar 09; 18(1):18-22. PubMed ID: 11354543
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, Strauch J, Koch A.
    J Pharmacol Exp Ther; 2010 Dec 09; 335(3):788-98. PubMed ID: 20801891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.